Skip to main content
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.20
+0.39 (3.98%)
At close: Jun 11, 2025, 4:00 PM
9.99
-0.21 (-2.06%)
Pre-market: Jun 12, 2025, 4:25 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gene Therapy
90.24M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapy Growth
-19.94%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
International
61.36M
Log In
Log In
Log In
Log In
Upgrade
International Growth
-1.02%
Log In
Log In
Log In
Log In
Upgrade
United States
28.88M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-26.81%
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Bermuda
-
Log In
Log In
Log In
Log In
Upgrade